8. Huntington disease
197 clinical trials,   171 drugs   (DrugBank: 54 drugs),   82 drug target genes,   144 drug target pathways

Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01458470
(ClinicalTrials.gov)
September 201120/10/2011A Trial of Memantine as Symptomatic Treatment for Early Huntington DiseaseA Trial of Memantine as Symptomatic Treatment for Early Huntington Disease; a Phase IIb StudyHuntington DiseaseDrug: Memantine;Other: PlaceboUniversity of British ColumbiaHuntington Society of Canada;Huntington Study GroupCompleted18 Years75 YearsAll19Phase 2Canada
2NCT00652457
(ClinicalTrials.gov)
November 23, 200431/3/2008Study of Memantine to Treat Huntington's DiseaseA Pilot Study of Memantine for Cognitive and Behavioral Dysfunction in Huntington's DiseaseHuntington's DiseaseDrug: MemantineJody Corey-Bloom, MD, PhDForest LaboratoriesCompleted18 YearsN/AAll60Phase 4United States